MATALUNI, GIORGIA
 Distribuzione geografica
Continente #
NA - Nord America 8.635
AS - Asia 1.866
EU - Europa 1.614
SA - Sud America 247
AF - Africa 23
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.392
Nazione #
US - Stati Uniti d'America 8.583
SG - Singapore 884
IT - Italia 660
CN - Cina 256
RU - Federazione Russa 216
BR - Brasile 209
KR - Corea 177
HK - Hong Kong 163
VN - Vietnam 150
IE - Irlanda 146
DE - Germania 120
GB - Regno Unito 95
UA - Ucraina 92
FR - Francia 74
BD - Bangladesh 71
NL - Olanda 58
JP - Giappone 55
FI - Finlandia 35
CA - Canada 31
IN - India 30
SE - Svezia 22
AT - Austria 19
TR - Turchia 15
CH - Svizzera 14
IQ - Iraq 14
AR - Argentina 13
PL - Polonia 11
RO - Romania 11
ZA - Sudafrica 11
ES - Italia 10
ID - Indonesia 7
CL - Cile 6
CO - Colombia 6
MX - Messico 6
KG - Kirghizistan 5
MY - Malesia 5
PK - Pakistan 5
PY - Paraguay 5
UZ - Uzbekistan 5
BE - Belgio 4
CZ - Repubblica Ceca 4
LU - Lussemburgo 4
PH - Filippine 4
TT - Trinidad e Tobago 4
AL - Albania 3
AU - Australia 3
DK - Danimarca 3
EG - Egitto 3
IR - Iran 3
PE - Perù 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BS - Bahamas 2
DZ - Algeria 2
EC - Ecuador 2
HR - Croazia 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
VE - Venezuela 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
KZ - Kazakistan 1
LT - Lituania 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 12.392
Città #
Wilmington 2.269
Houston 1.989
Woodbridge 1.801
Singapore 488
Chandler 262
San Jose 203
Fairfield 176
New York 160
Hong Kong 159
Ashburn 141
Dublin 137
Ann Arbor 112
Beijing 97
Rome 90
Medford 86
Santa Clara 84
Cambridge 72
Seattle 71
Milan 58
Los Angeles 57
The Dalles 55
Dearborn 54
Ho Chi Minh City 53
Tokyo 49
Jacksonville 48
Lawrence 41
Moscow 40
Hanoi 38
Lauterbourg 38
Dallas 35
Buffalo 33
Council Bluffs 30
North Bergen 24
São Paulo 24
Redondo Beach 20
Turin 20
Naples 18
Piove di Sacco 17
Roebling 17
San Diego 17
Munich 15
Nuremberg 15
Palo Alto 14
Bologna 13
London 12
Seoul 12
Atlanta 10
Florence 10
Orem 10
Lappeenranta 9
Palermo 9
Verona 9
Amsterdam 8
Creede 8
Helsinki 8
Montreal 8
Redwood City 8
San Francisco 8
Vienna 8
Basingstoke 7
Haiphong 7
Istanbul 7
Manchester 7
Salt Lake City 7
Warsaw 7
Chennai 6
Elk Grove Village 6
Lodi 6
Mülheim 6
Norwalk 6
Paris 6
Chengdu 5
Da Nang 5
Kilburn 5
Menlo Park 5
Tooting 5
Toronto 5
Vicenza 5
Ankara 4
Belo Horizonte 4
Bergamo 4
Boardman 4
Boston 4
Brno 4
Brooklyn 4
Chicago 4
Engelhard 4
Erbil 4
Frankfurt am Main 4
Guangzhou 4
Inverigo 4
Jakarta 4
Jinan 4
Johannesburg 4
Karbala 4
Kuala Lumpur 4
Kunming 4
Lausanne 4
Modena 4
Mountain View 4
Totale 9.578
Nome #
Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies 493
Acute disseminated encephalomyelitis following Campylobacter jejuni gastroenteritis: Case report and review of the literature 464
Central and peripheral nervous system involvement as a manifestation of graft versus host disease after liver transplantation: case report 459
International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome 455
IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy 452
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 437
EPIDEMIOLOGY AND POTENTIAL PROGNOSTIC FACTORS IN GUILLAIN-BARRE SYNDROME: TEN-YEAR EXPERIENCE OF "POLICLINICO TOR VERGATA" 430
Bickerstaff encephalitis with anti gm1-antibodies relapsing as guillain-barre syndrome: a case report 424
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 415
Bickerstaff encephalitis: report of two atypical cases with negative anti GQ1B antibodies 409
Autonomic nervous system involvement in patients with chronic dysimmune neuropathies 381
Meningomyeloradiculitis mimicking recurrent bilateral neuralgic amyotrophy. 378
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 378
Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 374
High dose intravenous immunoglobulin is effective in painful diabetic polyneuropathy resistant to conventional treatments: results of a double blind, randomized, placebo-controlled, multicenter trial 351
Motor unit number estimation in 30 patients with chronic dysimmune neuropathies 342
Neuroretinal dysfunction is associated with early peripheral motor unit loss in type 1 diabetes 337
Regional variation of Guillain-Barré syndrome 328
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 321
Miscarriage induces reactivation of inflammation in relapsing-remitting multiple sclerosis 317
Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 302
Neuroretinal Dysfunction Is Associated with Early Peripheral Motor Unit Loss in Type 1 Diabetes Mellitus 267
Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus 262
PREVALENCE OF ANTI-NEUROFASCIN-155, ANTI-CONTACTIN-1 AND ANTI-CONTACTIN-ASSOCIATED PROTEIN-1 ANTIBODIES IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A SEROLOGICAL MULTICENTER STUDY IN ITALY 251
PREVALENCE OF ANTI-NEUROFASCIN-155, ANTI-CONTACTIN-1 AND CONTACTIN-ASSOCIATED PROTEIN 1 ANTIBODIES IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A SEROLOGICAL MULTICENTER STUDY IN ITALY 244
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis 206
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis 182
Current treatment practice of Guillain-Barré syndrome 165
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 156
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 149
Anti-HBs titers are not decreased after treatment with oral Cladribine in patients with Multiple Sclerosis vaccinated against Hepatitis B virus 144
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 132
Assessment of macular function by multifocal electroretinogram in patients with multiple sclerosis treated with fingolimod 124
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP 122
Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis 122
Correction to: Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 111
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 110
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database 105
Multifocal Electroretinogram Photopic Negative Response: A Reliable Paradigm to Detect Localized Retinal Ganglion Cells' Impairment in Retrobulbar Optic Neuritis Due to Multiple Sclerosis as a Model of Retinal Neurodegeneration 103
Patient's point of view on the use of telemedicine in multiple sclerosis: a web-based survey 96
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 90
The neurophysiological lesson from the Italian CIDP database 87
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 85
null 81
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection 79
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 75
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 70
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 70
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 67
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 61
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 58
COVID-19 vaccine hesitancy among Italian people with multiple sclerosis 58
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 55
Structural and Functional Assessment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes Without History of Optic Neuropathy 55
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 54
Impact of environmental factors and physical activity on disability and quality of life in CIDP 53
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values 50
Response to Dr. Wee 49
Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy 49
High-Dose Intravenous Immunoglobulin Is Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial 45
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 6
null 3
Totale 12.598
Categoria #
all - tutte 38.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.075


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 0 0 0 0 0 0 22
2021/2022433 28 35 13 38 24 42 13 19 32 38 28 123
2022/2023851 53 58 100 125 59 159 89 38 79 5 62 24
2023/2024376 62 12 26 22 29 60 27 11 23 22 3 79
2024/20251.448 45 298 155 106 69 130 64 69 164 134 126 88
2025/20262.240 150 92 267 133 219 54 378 227 256 194 171 99
Totale 12.598